Edgewise Therapeutics Shares Rise Following Reports of Potential Takeover Interest
Shares of Edgewise Therapeutics (EWTX) surged by approximately 12% following reports suggesting the biopharmaceutical company has attracted takeover interest. According to market traders citing a Betaville alert, the firm may have engaged financial advisers to initiate a formal sales process. The speculation regarding a potential acquisition has driven immediate investor interest in the NASDAQ-listed biotech company. While no official confirmation or specific bidder has been named, the report highlights growing M&A activity and strategic interest within the biopharmaceutical sector.